The Friday Letter is the Association of Schools and Programs of Public Health's weekly e-newsletter featuring the latest research, opportunities and developments from CEPH-accredited schools and programs of public health.
Dr. Jennifer L. Temple, associate professor of nutrition, and director of UB’s Nutrition and Health Research Laboratory, recently offered expert opinion to a question submitted to The Conversation, on whether any level of caffeine is safe for teens to ingest.
Renewal of the grant allows researchers and clinicians at UB and its partners in the Buffalo Translational Consortium to continue to innovate, speeding the development of new treatments for disease, reducing health disparities and allowing more Western New Yorkers to benefit from clinical research.
Team Epigeniuses won the competition. Their innovation was a multi-day community-based intervention to educate women over the age of 12 in Abuja, Nigeria, on the transgenerational epigenetic effects of exposure to alcohol or drugs during pregnancy.
Researchers quizzed cannabis enthusiasts at a marijuana advocacy event about their beliefs on whether the drug is effective in treating certain medical conditions. The majority of the nearly 500 people surveyed failed the quiz, according to the best science available.
A UB epidemiologist and two graduates of the epidemiology PhD program contributed to a significant Centers for Disease Control and Prevention report published in the New England Journal of Medicine that links vitamin E acetate as an e-cigarette additive to the outbreak of e-cigarette, or vaping, product-use associated lung injury cases.
The three projects selected for pilot grants have the broader aim of understanding how obesity develops and what systems might treat it. The projects include one led by Dr. Elizabeth G. Mietlicki-Baase, assistant professor of exercise and nutrition sciences, that will look at the peptide hormone amylin, thought to be a promising target for obesity, and how it taps into reward processing.